Citation Tools

Download PDFPDF
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration

Download to a citation manager

Cite this article as:
Krebs I, Schmetterer L, Boltz A, et al
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration